Published in Hered Cancer Clin Pract on September 15, 2004
A meta-analysis of clinical electro-oculography values. Doc Ophthalmol (2017) 0.75
Standard for clinical electro-oculography. International Society for Clinical Electrophysiology of Vision. Doc Ophthalmol (1993) 2.46
Current understanding on the role of retinal pigment epithelium and its pigmentation. Pigment Cell Res (1999) 1.51
The neurofibromatosis type 1 gene and its protein product, neurofibromin. Neuron (1993) 1.36
Interaction between chemicals and melanin. Pigment Cell Res (1993) 1.34
Ultrastructure of giant pigment granules (macromelanosomes) in the cutaneous pigmented macules of neurofibromatosis. J Invest Dermatol (1973) 1.24
Standardization notice: EOG standard reapproved. Electro-oculogram. Doc Ophthalmol (1998) 1.03
Ras-GTP regulation is not altered in cultured melanocytes with reduced levels of neurofibromin derived from patients with neurofibromatosis 1 (NF1). Biol Chem Hoppe Seyler (1995) 0.97
Increased melanogenesis in cultured epidermal melanocytes from patients with neurofibromatosis 1 (NF 1). Hum Genet (1991) 0.96
Neurofibromatosis type 1--an update and review for the primary pediatrician. Clin Pediatr (Phila) (1996) 0.91
Chloride currents in freshly isolated rat retinal pigment epithelial cells. Exp Eye Res (1994) 0.86
Does melanin do more than protect from light? Neurosci Res Suppl (1987) 0.85
Ophthalmological issues in the neurofibromatoses. J Pediatr Ophthalmol Strabismus (1996) 0.85
Electro-oculography as a test of retinal function. The normal and supernormal EOG. Am J Ophthalmol (1970) 0.85
Neurofibromatosis type 1. Beyond positional cloning. Arch Neurol (1993) 0.79
Electro-oculogram in patients with neurofibromatosis type 1. Doc Ophthalmol (2001) 0.79
Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies. J Natl Cancer Inst (2010) 4.54
A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2. Nat Genet (2009) 4.38
Genome-wide association study identifies three loci associated with melanoma risk. Nat Genet (2009) 3.89
GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer. Nat Genet (2013) 3.42
Genome-wide association study identifies three new melanoma susceptibility loci. Nat Genet (2011) 2.29
The NOD2 3020insC mutation and the risk of colorectal cancer. Cancer Res (2004) 2.01
A high proportion of founder BRCA1 mutations in Polish breast cancer families. Int J Cancer (2004) 1.96
Risk of breast cancer in women with a CHEK2 mutation with and without a family history of breast cancer. J Clin Oncol (2011) 1.94
Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer. Nat Commun (2013) 1.73
A genome-wide association study of upper aerodigestive tract cancers conducted within the INHANCE consortium. PLoS Genet (2011) 1.68
A novel founder CHEK2 mutation is associated with increased prostate cancer risk. Cancer Res (2004) 1.60
Early radiation exposures and BRCA1-associated breast cancer in young women from Poland. Breast Cancer Res Treat (2008) 1.59
Genetic variation at 9p22.2 and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers. J Natl Cancer Inst (2010) 1.41
Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31. Nat Commun (2013) 1.36
A deletion in CHEK2 of 5,395 bp predisposes to breast cancer in Poland. Breast Cancer Res Treat (2006) 1.34
Mutation analysis of MLH1 and MSH2 genes performed by denaturing high-performance liquid chromatography. J Biochem Biophys Methods (2002) 1.30
Hereditary ovarian cancer in Poland. Int J Cancer (2003) 1.30
A variant in FTO shows association with melanoma risk not due to BMI. Nat Genet (2013) 1.17
Common alleles in candidate susceptibility genes associated with risk and development of epithelial ovarian cancer. Int J Cancer (2011) 1.17
Germline 657del5 mutation in the NBS1 gene in breast cancer patients. Int J Cancer (2003) 1.13
Interplay between BRCA1 and RHAMM regulates epithelial apicobasal polarization and may influence risk of breast cancer. PLoS Biol (2011) 1.12
Mitochondrial NADH-dehydrogenase subunit 3 (ND3) polymorphism (A10398G) and sporadic breast cancer in Poland. Breast Cancer Res Treat (2009) 1.05
Polymorphism in the P-glycoprotein drug transporter MDR1 gene: a possible link between environmental and genetic factors in Parkinson's disease. Pharmacogenetics (2003) 1.04
Germline CHEK2 mutations and colorectal cancer risk: different effects of a missense and truncating mutations? Eur J Hum Genet (2006) 1.02
BRCA1 mutations and prostate cancer in Poland. Eur J Cancer Prev (2008) 1.01
Breast cancer risk reduction associated with the RAD51 polymorphism among carriers of the BRCA1 5382insC mutation in Poland. Cancer Epidemiol Biomarkers Prev (2003) 0.99
A low selenium level is associated with lung and laryngeal cancers. PLoS One (2013) 0.99
The 3020insC allele of NOD2 predisposes to early-onset breast cancer. Breast Cancer Res Treat (2005) 0.99
Methylenetetrahydrofolate reductase polymorphisms modify BRCA1-associated breast and ovarian cancer risks. Breast Cancer Res Treat (2006) 0.98
The G84E mutation in the HOXB13 gene is associated with an increased risk of prostate cancer in Poland. Prostate (2013) 0.97
Polymorphism in the P-glycoprotein drug transporter MDR1 gene in colon cancer patients. Eur J Clin Pharmacol (2005) 0.96
BRCA1-associated breast and ovarian cancer risks in Poland: no association with commonly studied polymorphisms. Breast Cancer Res Treat (2009) 0.95
Sodium iodate selectively injuries the posterior pole of the retina in a dose-dependent manner: morphological and electrophysiological study. Neurochem Res (2010) 0.95
Topical dorzolamide treatment of macular cysts in the enhanced S-cone syndrome patient. Doc Ophthalmol (2013) 0.94
Can selenium levels act as a marker of colorectal cancer risk? BMC Cancer (2013) 0.93
Inflammatory response gene polymorphisms and their relationship with colorectal cancer risk. BMC Cancer (2008) 0.92
Comparison of genomic abnormalities between BRCAX and sporadic breast cancers studied by comparative genomic hybridization. Int J Cancer (2005) 0.92
The risk of gastric cancer in carriers of CHEK2 mutations. Fam Cancer (2013) 0.91
Germline mutation and large deletion analysis of the CDKN2A and ARF genes in families with multiple melanoma or an aggregation of malignant melanoma and breast cancer. Int J Cancer (2004) 0.91
Do BRCA1 modifiers also affect the risk of breast cancer in non-carriers? Eur J Cancer (2008) 0.90
Association of common WRAP 53 variant with ovarian cancer risk in the Polish population. Mol Biol Rep (2012) 0.90
Prevalence of the NOD2 3020insC mutation in aggregations of breast and lung cancer. Breast Cancer Res Treat (2006) 0.89
The VEGF_936_C>T 3'UTR polymorphism reduces BRCA1-associated breast cancer risk in Polish women. Cancer Lett (2008) 0.89
BRCA1 mutations and colorectal cancer in Poland. Fam Cancer (2010) 0.89
Sulforaphane-mediated induction of a phase 2 detoxifying enzyme NAD(P)H:quinone reductase and apoptosis in human lymphoblastoid cells. Acta Biochim Pol (2004) 0.89
A common nonsense mutation of the BLM gene and prostate cancer risk and survival. Gene (2013) 0.89
A six-nucleotide deletion in the CASP8 promoter is not associated with a susceptibility to breast and prostate cancers in the Polish population. Breast Cancer Res Treat (2007) 0.89
High incidence of 4153delA BRCA1 gene mutations in Lithuanian breast- and breast-ovarian cancer families. Breast Cancer Res Treat (2005) 0.88
A sex-specific association between a 15q25 variant and upper aerodigestive tract cancers. Cancer Epidemiol Biomarkers Prev (2011) 0.88
Smoking related cancers and loci at chromosomes 15q25, 5p15, 6p22.1 and 6p21.33 in the Polish population. PLoS One (2011) 0.88
Germline mutations in the CHEK2 kinase gene are associated with an increased risk of bladder cancer. Int J Cancer (2008) 0.88
The rs1447295 and DG8S737 markers on chromosome 8q24 and cancer risk in the Polish population. Eur J Cancer Prev (2010) 0.87
CHEK2 mutations and HNPCC-related colorectal cancer. Int J Cancer (2010) 0.87
CDKN2A-positive breast cancers in young women from Poland. Breast Cancer Res Treat (2006) 0.87
Synergistic interaction of variants in CHEK2 and BRCA2 on breast cancer risk. Breast Cancer Res Treat (2008) 0.87
DNA variation in MSR1, RNASEL and E-cadherin genes and prostate cancer in Poland. Urol Int (2007) 0.87
Pathology of breast cancer in women with constitutional CHEK2 mutations. Breast Cancer Res Treat (2005) 0.86
CHEK2 germline mutations correlate with recurrence rate in patients with superficial bladder cancer. Ann Acad Med Stetin (2008) 0.85
Polymorphisms in nucleotide excision repair genes and susceptibility to colorectal cancer in the Polish population. Mol Biol Rep (2014) 0.85
Clinical characteristics of laryngeal cancer in BRCA-1 mutation carriers. Anticancer Res (2009) 0.85
The 3' untranslated region C > T polymorphism of prohibitin is a breast cancer risk modifier in Polish women carrying a BRCA1 mutation. Breast Cancer Res Treat (2006) 0.85
Fine mapping of genetic susceptibility loci for melanoma reveals a mixture of single variant and multiple variant regions. Int J Cancer (2014) 0.84
Exploring the link between germline and somatic genetic alterations in breast carcinogenesis. PLoS One (2010) 0.83
Association between early-onset breast and laryngeal cancers. Breast Cancer Res Treat (2005) 0.83
Germline 657del5 mutation in the NBS1 gene in patients with malignant melanoma of the skin. Melanoma Res (2003) 0.83
CDH1 gene mutations do not contribute in hereditary diffuse gastric cancer in Poland. Fam Cancer (2010) 0.83
PARS PLANA VITRECTOMY IN ADVANCED CASES OF VON HIPPEL-LINDAU EYE DISEASE. Retina (2016) 0.82
Direct-to-patient BRCA1 testing: the Twoj Styl experience. Breast Cancer Res Treat (2006) 0.82
Cancer Familial Aggregation (CFA) and G446A polymorphism in ARLTS1 gene. Breast Cancer Res Treat (2006) 0.81
BARD1 and breast cancer in Poland. Breast Cancer Res Treat (2007) 0.81
The association between the interleukin-1 polymorphisms and gastric cancer risk depends on the family history of gastric carcinoma in the study population. Am J Gastroenterol (2006) 0.80
Clinical characteristics of tumors derived from colorectal cancer patients who harbor the tumor necrosis factor alpha-1031T/T and NOD2 3020insC polymorphism. Cancer Epidemiol (2009) 0.80
Genetic heterogeneity of 8q24 region in susceptibility to cancer. J Natl Cancer Inst (2009) 0.80
Rarity of germline 1100delC mutation in CHK2 in patients with malignant melanoma of the skin. Melanoma Res (2004) 0.80
Antigens HLA-G, sHLA- G and sHLA- class I in reproductive failure. Folia Histochem Cytobiol (2007) 0.80
Gene Expression Profiling in Hereditary, BRCA1-linked Breast Cancer: Preliminary Report. Hered Cancer Clin Pract (2006) 0.80
A 43-year-old man with reduced visual acuity and normal fundus: occult macular dystrophy--case report. Doc Ophthalmol (2007) 0.80
The presence of prostate cancer at biopsy is predicted by a number of genetic variants. Int J Cancer (2013) 0.79
[Germinal cell tumors in young and adolescent girls]. Ginekol Pol (2003) 0.78
Identification of patients at high risk of psychological distress after BRCA1 genetic testing. Genet Test Mol Biomarkers (2009) 0.78
Case report of a woman with monoclonal gammapathy and papillary thyroid carcinoma, diagnosed because of detection of CHEK2 (I157T) mutation in genetic examinations. Endokrynol Pol (2010) 0.78
Low-risk Genes and Multi-organ Cancer Risk in the Polish Population. Hered Cancer Clin Pract (2006) 0.78
Ovarian cancer of endometrioid type as part of the MSH6gene mutation phenotype. J Hum Genet (2002) 0.78
Polymorphic variants in VAX1 gene (rs7078160) and BMP4 gene (rs762642) and the risk of non-syndromic orofacial clefts in the Polish population. Dev Period Med (2014) 0.78
The photopic negative response as a promising diagnostic tool in glaucoma. A review. Klin Oczna (2012) 0.78
The 3020insC NOD2 gene mutation in patients with ovarian cancer. Ginekol Pol (2008) 0.77
Optimizing recruitment to a prostate cancer surveillance program among male BRCA1 mutation carriers: invitation by mail or by telephone. Hered Cancer Clin Pract (2013) 0.77
Consortium analysis of gene and gene-folate interactions in purine and pyrimidine metabolism pathways with ovarian carcinoma risk. Mol Nutr Food Res (2014) 0.77
Population screening for cancer family syndromes in the west pomeranian region of poland. Hered Cancer Clin Pract (2006) 0.77
The variant allele of the rs188140481 polymorphism confers a moderate increase in the risk of prostate cancer in Polish men. Eur J Cancer Prev (2015) 0.77
Is there any relationship between BRCA1 gene mutation and pancreatic cancer development? Pol Arch Med Wewn (2008) 0.77
Ovarian cancer risk in Polish BRCA1 mutation carriers is not associated with the prohibitin 3' untranslated region polymorphism. BMC Cancer (2008) 0.76
Combined iPLEX and TaqMan assays to screen for 45 common mutations in Lynch syndrome and FAP patients. J Mol Diagn (2009) 0.76
A Lowering of Breast and Ovarian Cancer Risk in Women with a BRCA1 Mutation by Selenium Supplementation of Diet. Hered Cancer Clin Pract (2006) 0.76
Double heterozygotes among breast cancer patients analyzed for BRCA1, CHEK2, ATM, NBN/NBS1, and BLM germ-line mutations. Breast Cancer Res Treat (2014) 0.75
Corrigendum: Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer. Nat Genet (2017) 0.75
Corrigendum: Germline RECQL mutations are associated with breast cancer susceptibility. Nat Genet (2016) 0.75
Coverage of the genetic background of breast cancer in the polish population. Hered Cancer Clin Pract (2006) 0.75